Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May:70:78-86.
doi: 10.1016/j.bcmd.2017.05.009. Epub 2017 May 20.

Oxidative pathways in the sickle cell and beyond

Affiliations
Review

Oxidative pathways in the sickle cell and beyond

Abdu I Alayash. Blood Cells Mol Dis. 2018 May.

Abstract

Polymerization of deoxy sickle cell hemoglobin (HbS) is well recognized as the primary event that triggers the classic cycles of sickling/unsickling of patients red blood cells (RBCs). RBCs are also subjected to continuous endogenous and exogenous oxidative onslaughts resulting in hemolytic rate increases which contribute to the evolution of vasculopathies associated with this disease. Compared to steady-state conditions, the occurrences of vaso-occlusive crises increase the levels of both RBC-derived microparticles as well as extracellular Hb in circulation. Common byproduct resulting from free Hb oxidation and from Hb-laden microparticles is heme (now recognized as damage associated molecular pattern (DAMP) molecule) which has been shown to initiate inflammatory responses. This review provides new insights into the interplay between microparticles, free Hb and heme focusing on Hb's pseudoperoxidative activity that drives RBC's cytosolic, membrane changes as well as oxidative toxicity towards the vascular system. Emerging antioxidative strategies that include the use of protein and heme scavengers in controlling Hb oxidative pathways are discussed.

Keywords: Ferryl hemoglobin; Heme oxidation; Microparticles; Pseudoperoxidase; Sickle cell hemoglobin.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Oxygenation and the pseudoperoxidase pathways in sickle cell hemoglobin
Hemoglobin (HbFeII) reversibly binds oxygen (koff/kon), and spontaneously oxidizes at a slow rate (kauto) to the non-functional ferric/metHb (HbFeIII) and superoxide (O2·−) that dismutate (kd) to give peroxide (H2O2). In the presence of this and/or exogenous H2O2, a catalytic cycle between the ferric (HbFeIII) and the ferryl (HbFeIV) hemes is initiated, in which H2O2 is eliminated in a peroxidase-like manner. However, in the case of HbS the autoreduction of ferryl back to ferric heme is slower (dotted line) than that of normal HbA, leading to a longer lived and more damaging ferrylHb [19]. If H2O2 reacts with the ferric form of Hb a protein radical is produce (.HbIV). The radical escapes through βCys93 resulting in its irreversible oxidation and the collapse of the β subunits. These oxidative changes then lead to unfolding and denaturation of the protein and heme loss. Heme is recognized as damage associated molecular pattern (DAMP) molecule able to trigger inflammation.
Figure 2
Figure 2. Proposed erythrocyte internal oxidative changes that trigger membrane alternations and microparticles formation
Oxidative reactions within RBCs include the following pathways: (1) Ferrous hemoglobin (FeII-O2) undergoes spontaneous oxidation (autooxidation) to form ferric (FeIII) and ferryl forms (FeIV). Ferryl species has been shown to form in sickle cells where antioxidative mechanisms are compromised. Ferryl Hb once formed undergoes oxidative changes including irreversible oxidation of βCys93 and ubiquitination of lysine 96. Ferryl Hb can oxidatively target band 3 leading to clustering of band3 and microparticles formation (2) or denaturation and proteasome degradation (3) some ferryl Hb revert back to ferric by a process of autoreduction (4). Hydroxyurea has been shown to have an antioxidant effects by minimizing the consequences of these processes.

References

    1. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science. 1949;110:543–548. - PubMed
    1. Dickerson RE, Gies I. Hemoglobin: structure, function, evolution, and pathology, The Benjamin/Cummings Publishing Company, California. 1983
    1. Hebbel RP. Ischemia-reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain. Hematol Oncol Clin North Am. 2014;28:181–198. - PubMed
    1. Wood KC, Granger DN. sickle cell disease: role for reactive oxygen and nitrogen metabolites. Clin Exp Pharm Physiol. 2007;34:926–932. - PubMed
    1. Connes PI, Lamarre Y, Waltz X, Ballas SK, Lemonne N, et al. Haemolysis and abnormal haemorheology in sickle cell anaemia. Br J Haematol. 2014;165:564–572. - PubMed

Publication types